Westlake Chemical Partners (WLKP) Receiving Somewhat Critical Press Coverage, Analysis Finds
Media headlines about Westlake Chemical Partners (NYSE:WLKP) have been trending somewhat negative on Saturday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Westlake Chemical Partners earned a daily sentiment score of 0.00 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 46.4165202502548 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:
- Analysts recommend to Strong Buy stock: Westlake Chemical Partners LP (WLKP) ,Ovid Therapeutics Inc. (OVID) – Street Observer (press release) (streetobserver.com)
- Negative stock of the month – Westlake Chemical Partners LP (WLKP) stock performed -5.02% down – Street Observer (press release) (streetobserver.com)
- Westlake Chemical Partners LP (WLKP) Prices 4.5M Common Share Offering at $22/Sh – StreetInsider.com (streetinsider.com)
- Westlake Chemical Partners Buys Deeper into OpCo Arm – Baystreet.ca (baystreet.ca)
- Westlake Chemical Partners LP C (NYSE:WLKP) Experiences Heavy Trading Volume – First News 24 (firstnewspaper24.com)
Westlake Chemical Partners (NYSE:WLKP) traded up 1.11% during trading on Friday, reaching $22.70. The company’s stock had a trading volume of 340,856 shares. The company has a market capitalization of $614.24 million, a P/E ratio of 15.97 and a beta of 1.24. The firm’s 50-day moving average price is $24.03 and its 200 day moving average price is $24.56. Westlake Chemical Partners has a 12-month low of $19.25 and a 12-month high of $26.25.
Westlake Chemical Partners (NYSE:WLKP) last issued its earnings results on Thursday, August 3rd. The basic materials company reported $0.36 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.41 by ($0.05). Westlake Chemical Partners had a return on equity of 4.34% and a net margin of 3.60%. The firm had revenue of $290.11 million during the quarter, compared to analysts’ expectations of $381.59 million. During the same quarter in the prior year, the company posted $0.34 earnings per share. Westlake Chemical Partners’s quarterly revenue was up 37.6% compared to the same quarter last year. On average, analysts predict that Westlake Chemical Partners will post $1.51 earnings per share for the current fiscal year.
WARNING: “Westlake Chemical Partners (WLKP) Receiving Somewhat Critical Press Coverage, Analysis Finds” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/09/30/westlake-chemical-partners-wlkp-receiving-somewhat-critical-press-coverage-analysis-finds.html.
Westlake Chemical Partners Company Profile
Westlake Chemical Partners LP is a limited partnership formed by Westlake Chemical Corporation (Westlake). The Company operates, acquires and develops ethylene production facilities and other assets. Its business and operations are conducted through Westlake Chemical OpCo LP (OpCo). OpCo sells ethylene to Westlake and others, as well as sells co-products of ethylene production, including propylene, crude butadiene, pyrolysis gasoline and hydrogen.
Receive News & Stock Ratings for Westlake Chemical Partners LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical Partners LP and related stocks with our FREE daily email newsletter.